DNA Approach

Using a DNA-templated synthesis approach, Harvard University's David Liu and colleagues have developed a compound that can inhibit the protein insulin-degrading enzyme (IDE), reports Susan Young Rojahn at MIT's Technology Review.

The gene encoding IDE is commonly mutated in people with type 2 diabetes, and Liu and his colleagues found that their IDE inhibitor increases insulin levels in both the blood of normal and obese mice.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.